SOMERSET, N.J., Dec. 3 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. (Nasdaq: VTIV) today provided updated information on its upcoming Investor Day, which will be held Tuesday, December 11th, 2007 in New York City. The event will be begin at 8:30 a.m., not 9:00 a.m. as announced earlier, and will conclude at noon, followed by lunch.
The agenda will include a business overview, presentations by the leaders of each of the four major divisions, and a look at inVentiv's growing focus on integrated services.
The event will be held at the offices of inVentiv's Chandler Chicco Agency (CCA) business unit, located at 450 West 15th Street, Suite #700 in New York City. Please go to http://selectsurvey.inventivcommunications.com/TakeSurvey.aspx?SurveyID=88K I95 6 to request an invitation. Those who do not have Internet access can call (732) 537-4804.
The meeting is open to analysts and investors and will be accessible by
live audio webcast on inVentiv Health's website at
slides also will be available for all participants and an archived version
of the webcast will be available on inVentiv Health's website for one week
following the presentation.
Webcast segments will include:
8:30 a.m. - 10:30 a.m. Overview and Divisional Presentations
11 a.m. - noon Integrated Opportunities, Summary and Discussion
To listen to the presentation live, please dial 800-358-8448 (Domestic) or 706-634-1367 (International). A replay of the call will be available immediately following the call through December 18, 2007 at 800-642-1687 (Domestic) or 706-645-9291 (International). The conference ID number for the replay is 23949575.
About inVentiv Health
inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 275 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.
|SOURCE inVentiv Health, Inc.|
Copyright©2007 PR Newswire.
All rights reserved